These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library. Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663 [TBL] [Abstract][Full Text] [Related]
3. Covalent modifier-type aggregation inhibitor of amyloid-β based on a cyclo-KLVFF motif. Kino R; Araya T; Arai T; Sohma Y; Kanai M Bioorg Med Chem Lett; 2015 Aug; 25(15):2972-5. PubMed ID: 26045033 [TBL] [Abstract][Full Text] [Related]
4. Identification of amyloid-beta binding sites using an antisense peptide approach. Milton NG; Mayor NP; Rawlinson J Neuroreport; 2001 Aug; 12(11):2561-6. PubMed ID: 11496149 [TBL] [Abstract][Full Text] [Related]
5. Prevention of amyloid-β fibril formation using antibodies against the C-terminal region of amyloid-β1-40 and amyloid-β1-42. Montañés M; Casabona D; Sarasa L; Pesini P; Sarasa M J Alzheimers Dis; 2013; 34(1):133-7. PubMed ID: 23160008 [TBL] [Abstract][Full Text] [Related]
6. Comparison of the aggregation properties, secondary structure and apoptotic effects of wild-type, Flemish and Dutch N-terminally truncated amyloid beta peptides. Demeester N; Mertens C; Caster H; Goethals M; Vandekerckhove J; Rosseneu M; Labeur C Eur J Neurosci; 2001 Jun; 13(11):2015-24. PubMed ID: 11422442 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of amyloid fibril formation and cytotoxicity by caffeic acid-conjugated amyloid-β C-terminal peptides. Arai T; Ohno A; Mori K; Kuwata H; Mizuno M; Imai K; Hara S; Shibanuma M; Kurihara M; Miyata N; Nakagawa H; Fukuhara K Bioorg Med Chem Lett; 2016 Nov; 26(22):5468-5471. PubMed ID: 27789140 [TBL] [Abstract][Full Text] [Related]
8. Modulating amyloid-β aggregation: The effects of peptoid side chain placement and chirality. Turner JP; Chastain SE; Park D; Moss MA; Servoss SL Bioorg Med Chem; 2017 Jan; 25(1):20-26. PubMed ID: 27776890 [TBL] [Abstract][Full Text] [Related]
9. The effect of Alzheimer's Aβ aggregation state on the permeation of biomimetic lipid vesicles. Williams TL; Day IJ; Serpell LC Langmuir; 2010 Nov; 26(22):17260-8. PubMed ID: 20923185 [TBL] [Abstract][Full Text] [Related]
10. Oriented epitaxial growth of amyloid fibrils of the N27C mutant beta 25-35 peptide. Karsai A; Murvai U; Soós K; Penke B; Kellermayer MS Eur Biophys J; 2008 Sep; 37(7):1133-7. PubMed ID: 18189132 [TBL] [Abstract][Full Text] [Related]
11. Strong inhibition of beta-amyloid peptide aggregation realized by two-steps evolved peptides. Ghimire Gautam S; Komatsu M; Nishigaki K Chem Biol Drug Des; 2015 Mar; 85(3):356-68. PubMed ID: 25082146 [TBL] [Abstract][Full Text] [Related]
12. The role of histidines in amyloid β fibril assembly. Brännström K; Islam T; Sandblad L; Olofsson A FEBS Lett; 2017 Apr; 591(8):1167-1175. PubMed ID: 28267202 [TBL] [Abstract][Full Text] [Related]
13. Interaction of glycine zipper fragments of Aβ-peptides with neuronal nitric oxide synthase: kinetic, thermodynamic and spectrofluorimetric analysis. Padayachee ER; Whiteley CG Neuropeptides; 2013 Jun; 47(3):171-8. PubMed ID: 23375441 [TBL] [Abstract][Full Text] [Related]
14. Determination of Size of Folding Nuclei of Fibrils Formed from Recombinant Aβ(1-40) Peptide. Grigorashvili EI; Selivanova OM; Dovidchenko NV; Dzhus UF; Mikhailina AO; Suvorina MY; Marchenkov VV; Surin AK; Galzitskaya OV Biochemistry (Mosc); 2016 May; 81(5):538-47. PubMed ID: 27297904 [TBL] [Abstract][Full Text] [Related]
15. Effect of Taiwan mutation (D7H) on structures of amyloid-β peptides: replica exchange molecular dynamics study. Truong PM; Viet MH; Nguyen PH; Hu CK; Li MS J Phys Chem B; 2014 Jul; 118(30):8972-81. PubMed ID: 25010208 [TBL] [Abstract][Full Text] [Related]
18. Randomization of amyloid-β-peptide(1-42) conformation by sulfonated and sulfated nanoparticles reduces aggregation and cytotoxicity. Saraiva AM; Cardoso I; Saraiva MJ; Tauer K; Pereira MC; Coelho MA; Möhwald H; Brezesinski G Macromol Biosci; 2010 Oct; 10(10):1152-63. PubMed ID: 20480510 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and evaluation of Trolox-conjugated amyloid-β C-terminal peptides for therapeutic intervention in an in vitro model of Alzheimer's disease. Arai T; Ohno A; Kazunori M; Kakizawa T; Kuwata H; Ozawa T; Shibanuma M; Hara S; Ishida S; Kurihara M; Miyata N; Nakagawa H; Fukuhara K Bioorg Med Chem; 2016 Sep; 24(18):4138-4143. PubMed ID: 27407032 [TBL] [Abstract][Full Text] [Related]
20. The interaction of the neurodegenerative fragment of the beta-amyloid peptide with phospholipid membranes. van Veen M; O'Shea P Biochem Soc Trans; 1995 Nov; 23(4):547S. PubMed ID: 8654732 [No Abstract] [Full Text] [Related] [Next] [New Search]